Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Adam McGechan"'
Autor:
Adam McGechan, Keri Wellington
Publikováno v:
CNS Drugs. 19:1057-1065
▲ Ramelteon, approved in the US for the treatment of insomnia characterised by difficulty with sleep onset, is a highly selective agonist for the melatonin MT1/MT2 receptors, which are believed to mediate the circadian rhythm in mammals. ▲ Ramelt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b04b32f162e65fb3840154344f45bf93
https://doi.org/10.2165/00023210-200519120-00007
https://doi.org/10.2165/00023210-200519120-00007
Autor:
Tracey Wright, Adam McGechan
Publikováno v:
Molecular Diagnosis. 7:49-55
In the US, one in every eight women will develop breast cancer in her lifetime. Despite the advances made in treating breast cancer, the causal mechanisms underlying this disease have yet to be fully elucidated; 85% of breast cancer cases occur spora
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2822ee438a7357613ced4b3e64f84c13
https://doi.org/10.2165/00066982-200307010-00009
https://doi.org/10.2165/00066982-200307010-00009
Publikováno v:
BMC Neurology. 2011, Vol. 11 Issue 1, p125-133. 9p. 4 Charts, 1 Graph.
Autor:
Swaisland, H. C.1 (AUTHOR) Helen.Swaisland@astrazeneca.com, Oliver, S. D.1 (AUTHOR), Morris, T.1 (AUTHOR), Jones, H. K.1 (AUTHOR), Bakhtyari, A.2 (AUTHOR), Mackey, A.1 (AUTHOR), McCormick, A. D.1 (AUTHOR), Slamon, D.1 (AUTHOR), Hargreaves, J. A.1 (AUTHOR), Millar, A.1 (AUTHOR), Taboada, M. T.1 (AUTHOR)
Publikováno v:
Xenobiotica. Jun2009, Vol. 39 Issue 6, p444-456. 13p. 2 Diagrams, 8 Charts, 5 Graphs.
Autor:
Tortorici, Michael, Toh, Melvin, Rahavendran, S., LaBadie, Robert, Alvey, Christine, Marbury, Thomas, Fuentes, Ernesto, Green, Matthew, Ni, Grace, Hee, Brian, Pithavala, Yazdi
Publikováno v:
Investigational New Drugs; Dec2011, Vol. 29 Issue 6, p1370-1380, 11p
Publikováno v:
International Journal of Clinical Pharmacology & Therapeutics; 2010, Vol. 48 Issue 11, p708-717, 10p
Autor:
Matt Hills
Before Saturday March 26th 2005,'Doctor Who'had been off the air as a regular, new TV series for more than fifteen years; until a production team led by Russell T. Davies re-imagined the programme so successfully, so triumphantly, that it's become an
